Precision oncology provides opportunities for targeting KRAS-inhibitor resistance
Martin Sattler, Atish Mohanty, Prakash Kulkarni, Ravi Salgia
Topics & Concepts
KRASDrug resistanceCancer researchCancerCancer drugsMutationBiologyTargeted therapyComputational biologyAcquired resistanceMolecular oncologyDrugPrecision medicineBioinformaticsMedicinePharmacologyGeneticsGeneColorectal cancerCarcinogenesisProtein Kinase Regulation and GTPase SignalingCellular transport and secretionMelanoma and MAPK Pathways